Home › CytRx Unveils Novel LADR (Linker Activated Drug Release) Technology Platform
 

Keywords :   


CytRx Unveils Novel LADR (Linker Activated Drug Release) Technology Platform

2015-07-01 08:34:27| drugdiscoveryonline Home Page

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today unveiled its proprietary LADR™ (Linker Activated Drug Release) technology platform, a discovery engine designed to leverage the Company's expertise in albumin biology and linker technology for the development of a new class of anti-cancer therapies

Tags: technology release drug platform

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Reddit shares jump after OpenAI ChatGPT deal
17.05Is China's bubble tea bubble about to burst?
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Business locked in expensive AI 'arms race'
17.05Is the move to electric cars running out of power?
17.05Pornhub partners with UK child abuse fighting charity
17.05Pornhub partners with UK child abuse fighting charity
More »